PT  - JOURNAL ARTICLE
AU  - Chauma, Shamen Susan
AU  - Wan, Chengsong
AU  - Dong, Willa
AU  - Fu, Xuezhen
AU  - Tucker, Joseph D
AU  - Marley, Gift
AU  - Tang, Weiming
TI  - Disclosure of Gender Identity among Transgender Individuals to Healthcare Professionals in China: An Online Cross-sectional Study
AID  - 10.1101/2022.08.26.22279241
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.08.26.22279241
4099  - http://medrxiv.org/content/early/2022/08/26/2022.08.26.22279241.short
4100  - http://medrxiv.org/content/early/2022/08/26/2022.08.26.22279241.full
AB  - Purpose Culture and stigma-relevant issues discourage transgender (TG) individuals in China from disclosing their gender identities. This limits their access to transgender competent health services. This study evaluates the factors associated with gender identity disclosure to health professionals among transgender individuals in China.Methods A cross-sectional study was conducted in nine cities across mainland China from December 2019 to June 2020 among transgender individuals. Participants completed questions covering socio-demographic information, HIV/STI testing, sexual behaviors, and access to medical and mental health services.Results Overall, 277 (85.5%) out of 324 transgender individuals were eligible to participate in the study. The mean age was 29±8 years old. Among them, 78% (192/277) had ever disclosed their gender identity to others, and 56% (155/277) had disclosed their gender identity to health professionals. 79.4% had ever tested for HIV (with an HIV prevalence of 9.1%), 47.3% had tested for other STIs, 42.6% had used hormone therapy, and 9.4% had undergone gender-affirming surgery. Results from the multivariable logistic regression demonstrated that compared to non-disclosers, disclosers were more likely to have tested for STIs (aOR=1.94, 95%CI: 1.12-3.39). Hormone intervention therapy (aOR=2.81, 95%CI: 1.56-5.05) and Pre-Exposure Prophylaxis (PrEP) use (aOR= 3.51, 95%CI: 1.12-10.97) were associated with gender identity disclosure to health professionals.Conclusions Low rates of gender identity disclosure to health professionals among transgender people may reflect fear of stigma and outing, suggesting the need for more trans-inclusive environments. More research is needed to understand the importance of disclosure in improving transgender health services.Summary A study among transgender individuals in nine cities across mainland China found that gender identity disclosers to health care professionals were more likely to test for STIs than nondisclosures.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study received support from internal institute funding from Zhuhai Center for Disease Prevention and Control. This work was also supported by the National Nature Science Foundation of China (81703282 and 81903371), the National Institutes of Health (NIAID 1R01AI114310-01, NIAID K24AI143471), NIMH (R34MH109359 and R34MH119963), and National Science and Technology Major Project (2018ZX10101-001-001-003). Willa Dong was funded by a Fulbright-Hays Doctoral Dissertation Research Abroad fellowship; the Graduate Tuition Incentive Scholarship and Dissertation Completion Fellowship, The Graduate School, The University of North Carolina at Chapel Hill; the STD/HIV T32 Pre-doctoral Training Program from the National Institute of Allergy and Infectious Diseases (grant number 5T32AI007001-42); The funders did not participate in the process of study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The authors thank all people who contributed.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Institutional Review Boards (IRB) #18-3215 of the UNC at Chapel Hill and the Dermatology Hospital of Southern Medical University before the survey's launch.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors